Mirae Asset Global Investments
KZR

Mirae Asset Global Investments’s Kezar Life Sciences KZR Stock Holding History

Mirae Asset Global Investments’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,620
Closed -$84.1K – 2070
2024
Q1 		$84.1K Buy
+2,620
New +$23.9K ﹤0.01% 2388
2023
Q2 		– Sell
-3,732
Closed -$117K – 2655
2023
Q1 		$117K Buy
3,732
+939
+34% +$54.3K ﹤0.01% 2421
2022
Q4 		$197K Buy
2,793
+946
+51% +$70.2K ﹤0.01% 2308
2022
Q3 		$159K Buy
1,847
+611
+49% +$59.4K ﹤0.01% 2405
2022
Q2 		$102K Buy
+1,236
New +$109K ﹤0.01% 2304

Other funds holding KZR

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Mirae Asset Global Investments's KZR Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Kezar Life Sciences (KZR) in Q2 2024, closing a stake of 2,620 shares — an estimated $84.1K sold.

Mirae Asset Global Investments first reported a position in KZR in Q2 2022 and held it in 5 quarters. The position peaked at $197K in Q4 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Kezar Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,620 Kezar Life Sciences shares in Q2 2024, an estimated $84.1K.
  • Mirae Asset Global Investments first reported a position in Kezar Life Sciences in Q2 2022 and held it in 5 quarters.
  • Mirae Asset Global Investments's Kezar Life Sciences position peaked at $197K in Q4 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.